# A Phase 1 Safety Study in Adults With Schizophrenia

> **NCT02804568** · PHASE1 · COMPLETED · sponsor: **Alkermes, Inc.** · enrollment: 42 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** ALKS 3831

## Key facts

- **NCT ID:** NCT02804568
- **Lead sponsor:** Alkermes, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2016-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02804568

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02804568, "A Phase 1 Safety Study in Adults With Schizophrenia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02804568. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*